Meanwhile, significantly lower expression levels of Mcl-1, Bcl-2 and Bcl-xL proteins were observed in the NSCLC cell lines treated with combination of RAD001 and CGP57380. This evidence concerns the gene BCL2L1 and non-small cell lung carcinoma.